Literature DB >> 3080061

Standards for the use of ordinal scales in clinical trials.

C R MacKenzie, M E Charlson.   

Abstract

Ordinal scales are frequently used in clinical trials to quantify outcomes which are non-dimensional. They may be regarded as either single state or transition measures based on whether they assess the outcome at a single point in time or directly examine change which has occurred between two points in time. Each has unique structural and operating characteristics, so that different methodological standards for their construction and utilisation are required. All trials employing ordinal scales published in three leading journals between 1980 and 1984 were examined. For both types of scales the individual ranks must be clearly defined, mutually exclusive, and ordered in a hierarchical progression. Further, both types must be able to detect equally both improvement and deterioration. For this to be ensured with the single state scales the population under study must not be clustered at one extreme of the scale at entry into the trial. With the transition scales internal symmetry must be achieved. Strategies for determining the comparisons to be performed should include emphasis on within patient analysis for crossover trials. Concordance between scale scores and the other measures of outcome employed in the trial must be evaluated. Frequent violations were uncovered in the studies reviewed, and it is hoped that the simple rules outlined will prove useful in the planning and evaluation of future trials.

Entities:  

Mesh:

Year:  1986        PMID: 3080061      PMCID: PMC1338986          DOI: 10.1136/bmj.292.6512.40

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  26 in total

1.  Hyperbaric-oxygen treatment of multiple sclerosis. A randomized, placebo-controlled, double-blind study.

Authors:  B H Fischer; M Marks; T Reich
Journal:  N Engl J Med       Date:  1983-01-27       Impact factor: 91.245

2.  Statistical validation of a severity of illness measure.

Authors:  D P Wagner; W A Knaus; E A Draper
Journal:  Am J Public Health       Date:  1983-08       Impact factor: 9.308

3.  A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction.

Authors:  J L Anderson; H W Marshall; B E Bray; J R Lutz; P R Frederick; F G Yanowitz; F L Datz; S C Klausner; A D Hagan
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

4.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial.

Authors:  D S Cooper; R Halpern; L C Wood; A A Levin; E C Ridgway
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

5.  Functional health status levels of primary care patients.

Authors:  E Nelson; B Conger; R Douglass; D Gephart; J Kirk; R Page; A Clark; K Johnson; K Stone; J Wasson; M Zubkoff
Journal:  JAMA       Date:  1983-06-24       Impact factor: 56.272

6.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

7.  The therapeutic efficacy of hemodialysis in schizophrenia.

Authors:  W T Carpenter; J H Sadler; P D Light; T E Hanlon; A A Kurland; M W Penna; W P Reed; E H Wilkinson; J J Bartko
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

8.  Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial.

Authors:  I L Dwosh; A R Giles; P M Ford; J L Pater; T P Anastassiades
Journal:  N Engl J Med       Date:  1983-05-12       Impact factor: 91.245

9.  Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.

Authors:  Y J Bryson; M Dillon; M Lovett; G Acuna; S Taylor; J D Cherry; B L Johnson; E Wiesmeier; W Growdon; T Creagh-Kirk; R Keeney
Journal:  N Engl J Med       Date:  1983-04-21       Impact factor: 91.245

10.  Does free care improve adults' health? Results from a randomized controlled trial.

Authors:  R H Brook; J E Ware; W H Rogers; E B Keeler; A R Davies; C A Donald; G A Goldberg; K N Lohr; P C Masthay; J P Newhouse
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

View more
  10 in total

1.  Use of different outcome measures in randomised studies of malignant glioma can significantly alter the interpretation of time to progression: reanalysis of the MRC BR2 study.

Authors:  J Chataway; S Stenning; N Bleehen; R Grant
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

2.  Design of treatment trials for functional gastrointestinal disorders.

Authors:  S J Veldhuyzen van Zanten; N J Talley; P Bytzer; K B Klein; P J Whorwell; A R Zinsmeister
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 3.  Assessment of reflux symptom severity: methodological options and their attributes.

Authors:  P Bytzer
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 4.  Measuring quality of life in clinical trials: a taxonomy and review.

Authors:  G H Guyatt; S J Veldhuyzen Van Zanten; D H Feeny; D L Patrick
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

5.  Clinical trials, statistics, and dilemmas.

Authors:  S McKenzie
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

Review 6.  Quality of life instruments in the evaluation of new drugs.

Authors:  R Jaeschke; G H Guyatt; D Cook
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

7.  Laboratory testing of muscle function in the management of neuromuscular disease.

Authors:  C M Wiles; Y Karni; J Nicklin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

8.  Recording neurological impairment in clinical trials of glioma.

Authors:  R Grant; J Slattery; A Gregor; I R Whittle
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Fluorotic cervical compressive myelopathy, 20 years after laminectomy: A rare event.

Authors:  Praveen Kumar; Ak Gupta; Shashank Sood; Ashok Kumar Verma
Journal:  Surg Neurol Int       Date:  2011-01-24

10.  Effects of the search technique on the measurement of the change in quality of randomized controlled trials over time in the field of brain injury.

Authors:  Mark K Borsody; Chisa Yamada
Journal:  BMC Med Res Methodol       Date:  2005-02-07       Impact factor: 4.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.